“flagship-ventures” Archives

in
Entry Author Date Location
Indigo Garners $56,000,000 Series B Financing Round 02/18/16 Boston
CRISPR Hits Wall Street as Editas Bags $94M in IPO 02/02/16 Boston
Early Bird Special Ends Today for New York’s Life Science Disruptors 02/02/16 New York
Tarveda Therapeutics Garners $38,000,000 Series C Funding Round 01/27/16 Boston
Ex-Biogen Exec’s New Startup Gets $61M More For Exosome Drugs 01/26/16 Boston
Codiak BioSciences Receives $61,000,000 Series B Financing Round 01/26/16 Boston
NYC’s Disruptive Biotech Startups take the Stage on March 29 01/21/16 New York
With Second Eye Drug Flop, Eleven Heads Back to Drawing Board 01/19/16 Boston
Eyeing First Trials, Syros Brings in $40M and More Crossovers 01/13/16 Boston
With $48M For Petra Pharma, Accelerator Places First NYC Bet 01/06/16 New York
Lab Space on a Navy Ship, And Other Creative Solutions for NY Biotech 01/05/16 New York
Eight Things You Might Not Have Known Until Editas Filed Its S-1 01/04/16 Boston
Amid Neuroscience Renaissance, BlackThorn Quietly Builds a Business 12/23/15 San Francisco
East Coast Biotech Roundup: ASH, Kallyope, SQZ, Kyras & More 12/11/15 Boston
With Startup, Bio Pioneer Tom Maniatis Looks to Spark NY Scene Again 12/10/15 New York
Rubius Therapeutics Garners $25,000,000 New Round 12/10/15 Boston
Rubius Aims To Turn Red Blood Cells Into Engineered Drug Carriers 12/09/15 Boston
Key for Houston’s Biotech Ecosystem? Building a Bench of Executives 12/07/15 Texas
East Coast Biotech Roundup: Pfizergan, Zafgen, Codiak, Boston Pharma 11/23/15 Boston
Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M 11/17/15 Boston
Flagship Merges Biofuel Maker Red Rock with R&D-Focused Joule 11/16/15 Boston
Ex-Blueprint Med CEO Resurfaces With $7.5M to Fight Genetic Blindness 11/09/15 Boston
East Coast Biotech Roundup: Bluebird, Solid GT, Evelo, Dyax & More 11/09/15 Boston
Evelo Therapeutics Receives $35,000,000 Seed Financing Round 11/05/15 Boston
Evelo Launches With $35M To Fight Cancer With Cocktails of Bacteria 11/04/15 Boston
Venture Veterans Frazier Commit New $262M Fund To Biopharma Bets 10/29/15 San Francisco
Taris 2.0: A Year After Buyout, VCs Bet $32M More on a Second Strike 10/27/15 Boston
TARIS Biomedical Receives $32,000,000 New Financing 10/27/15 Boston
Boston’s Life Science Disruptors 2015: The Photos 10/06/15 Boston
Five Takeaways From “Boston’s Life Science Disruptors” 10/02/15 Boston
Page 2 of 16 « previous page · next page »